Approvals/TGA/GLYCOPHOS sodium glycerophosphate (as hydrate) 4.32 g/20 mL concentrated solution for injection

Approved

STANDARD

GLYCOPHOS sodium glycerophosphate (as hydrate) 4.32 g/20 mL concentrated solution for injection

Fresenius Kabi Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 2170b3208faccefe
Product Name: GLYCOPHOS sodium glycerophosphate (as hydrate) 4.32 g/20 mL concentrated solution for injection
Artg Id: 312021
Artg Name: GLYCOPHOS sodium glycerophosphate (as hydrate) 4.32 g/20 mL concentrated solution for injection ampoule
Sponsor: Fresenius Kabi Australia Pty Ltd
Company Detail Path: /organization/fresenius-kabi-australia-pty-ltd
Artg Date: 2019-11-14
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/35959a12a177e5cafcf85098fa6055fd.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/66da37bad934eb2d6ce29d097b9014c8.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

2170b3208faccefe

Type

Standard